PAMLECTABART
UNII XMS5Q5W5V7

Substance Identification & Data

This profile provides standardized clinical and technical data for Pamlectabart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XMS5Q5W5V7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2925692-65-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XMS5Q5W5V7

CAS Registry Number

2925692-65-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PAMLECTABART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211821

National Cancer Institute reference terminology for clinical and research data.

INN ID

13245

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pamlectabart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-450) (VH (HOMO SAPIENS IGHV3-74*01 (84.5%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT (8.8.13) (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14, G1V76 CH2 C27 (CH1 R120>K (217) (121-218), HINGE 1-15 (219-233), CH2 D27>C (268) (234-343), CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)), (223-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (90.5%) -IGKJ2*01 (81.8%) Q120>A (100'), I126>L (106'), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (268-CYSTEINE), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN-MUS MUSCULUS MONOCLONAL J22.9-ISY .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL J22.9-ISY .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF17 (TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, TNFRSF13A, CD269)), HUMANIZED MONOCLONAL ANTIBODY;

PAMLECTABART

PAMLECTABART [INN]